X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (102) 102
Patent (13) 13
Publication (11) 11
Newspaper Article (8) 8
Dissertation (3) 3
Book / eBook (2) 2
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
index medicus (32) 32
female (20) 20
male (20) 20
middle aged (19) 19
oncology (18) 18
hematology (16) 16
aged (15) 15
adult (14) 14
measuring (13) 13
physics (13) 13
testing (13) 13
arrangements for measuring two or more variables not coveredin a single other subclass (12) 12
calculating (12) 12
computing (12) 12
counting (12) 12
electric digital data processing (12) 12
handling record carriers (12) 12
measuring not specially adapted for a specific variable (12) 12
measuring or testing not otherwise provided for (12) 12
presentation of data (12) 12
recognition of data (12) 12
record carriers (12) 12
tariff metering apparatus (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
treatment outcome (10) 10
abridged index medicus (9) 9
cancer (9) 9
lymphomas (9) 9
phase-ii (9) 9
aged, 80 and over (8) 8
chemotherapy (8) 8
prognosis (8) 8
article (7) 7
myc (7) 7
non-hodgkin lymphoma (7) 7
rituximab (7) 7
young adult (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
b-cell lymphoma (6) 6
care and treatment (6) 6
lymphoma (6) 6
transplantation (6) 6
analysis (5) 5
animals (5) 5
cyclophosphamide - therapeutic use (5) 5
disease-free survival (5) 5
doxorubicin - therapeutic use (5) 5
expression (5) 5
hemic and lymphatic diseases (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
neoplasm staging (5) 5
prednisone - therapeutic use (5) 5
remission induction (5) 5
research (5) 5
retrospective studies (5) 5
survival analysis (5) 5
vincristine - therapeutic use (5) 5
antineoplastic agents - therapeutic use (4) 4
bcl2 (4) 4
biomarkers (4) 4
disease (4) 4
estate planning (4) 4
follow-up (4) 4
lymphoma, b-cell - genetics (4) 4
lymphoma, large b-cell, diffuse - pathology (4) 4
multivariate analysis (4) 4
patient outcomes (4) 4
risk factors (4) 4
salvage therapy (4) 4
stem cell transplantation (4) 4
stem cells (4) 4
survival (4) 4
survival rate (4) 4
therapy (4) 4
usage (4) 4
allergy and immunology (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antineoplastic agents - adverse effects (3) 3
biomarkers, tumor - genetics (3) 3
cell differentiation (3) 3
chronic lymphocytic-leukemia (3) 3
clinical trials (3) 3
combined modality therapy (3) 3
diagnosis (3) 3
dna-binding proteins - genetics (3) 3
etoposide (3) 3
etoposide - therapeutic use (3) 3
gene rearrangement (3) 3
health aspects (3) 3
hodgkin disease - diagnosis (3) 3
hodgkin disease - drug therapy (3) 3
immune system diseases (3) 3
lymphoma, large b-cell, diffuse - mortality (3) 3
lymphoma, non-hodgkin - diagnosis (3) 3
lymphoma, non-hodgkin - drug therapy (3) 3
lymphoma, non-hodgkin - pathology (3) 3
methotrexate - therapeutic use (3) 3
mice (3) 3
non-hodgkin's lymphomas (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 02/2011, Volume 117, Issue 3, pp. 581 - 589
BACKGROUND: Primary cardiac lymphoma (PCL) represents a rare subset of non‐Hodgkin lymphoma, characterized by poor outcomes. The authors aimed to construct a... 
non‐Hodgkin lymphoma | primary cardiac lymphoma | extra nodal lymphoma | immunocompromise | non-Hodgkin lymphoma
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB232 - AB232
  [...]BAT responses to a non-IgE-dependent stimulus, formyl-methionyl-leucyl-phenylalanine, were unaffected or minimally altered. 
Allergy and Immunology | Medical colleges | Medical tests | Usage | Cancer patients | Skin | Drug therapy | Allergies
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2017, Volume 140, Issue 3, pp. 875 - 879.e1
Tyrosine kinases, including Bruton's tyrosine kinase (BTK), have been shown to be critical for allergen reactivity by transducing Fc[epsilon]RI crosslinking... 
Allergy and Immunology | Tyrosine | Food allergies | Leukemia | Immunoproliferative diseases | Asthma | Studies | Anaphylaxis | Lymphocytes | Skin | Lymphomas | Protein-tyrosine kinase | Drug dosages | Skin tests
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2016, Volume 175, Issue 4, pp. 631 - 640
Summary Rearrangement of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma (DLBCL) and B cell lymphoma unclassifiable... 
fluorescence in situ hybridization | B cell lymphoma unclassifiable | diffuse large B cell lymphoma | chemotherapy | MYC | SURVIVAL | TRANSLOCATION | IMMUNOCHEMOTHERAPY | R-CHOP | CLASSIFICATION | TRANSPLANTATION | IMPACT | fluorescence insitu hybridization | BURKITT-LYMPHOMA | FEATURES INTERMEDIATE | HEMATOLOGY | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Humans | Lymphoma, B-Cell - diagnosis | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Genes, myc | Lymphoma, B-Cell - genetics | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, B-Cell - mortality | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Proportional Hazards Models | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Gene Rearrangement | Vincristine - therapeutic use | Biomarkers | Vincristine - adverse effects | Aged | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphomas | Gene amplification | B cell lymphoma | CHEMOTHERAPY | Gene rearrangement
Journal Article
British Journal of Haematology, ISSN 0007-1048, 04/2017, Volume 177, Issue 1, pp. 72 - 79
Journal Article
Cancer, ISSN 0008-543X, 12/2014, Volume 120, Issue 24, pp. 3884 - 3895
Journal Article
Blood, ISSN 0006-4971, 10/2014, Volume 124, Issue 15, pp. 2354 - 2361
Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a... 
REARRANGEMENT | SURVIVAL | TRANSLOCATION | POOR-PROGNOSIS | RITUXIMAB | MYC | PHASE-II | GERMINAL CENTER | INDEX | HEMATOLOGY | EXPRESSION | Multivariate Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Remission Induction | Stem Cell Transplantation | Young Adult | Disease-Free Survival | Lymphoma - therapy | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 778 - 783
Journal Article